Pre-surgical tumor embolization is a preoperative interventional procedure used to reduce blood flow to a hypervascular tumor before surgical resection. This guide reviews the clinical rationale, procedural concepts, and embolic material considerations relevant to interventional and surgical teams collaborating on tumor management.
What Is the Clinical Rationale for Pre-Surgical Embolization?
Some tumors—particularly certain central nervous system tumors, spinal tumors, and hypervascular soft tissue or bone lesions—develop an extensive and often abnormal blood supply. When these tumors are resected surgically without prior intervention, intraoperative bleeding can be substantial, potentially prolonging operative time and increasing procedural complexity.
Pre-surgical embolization is intended to reduce a tumor's blood supply in the days immediately before planned surgical resection, with the general clinical goal of decreasing intraoperative blood loss and potentially improving surgical visualization of the tumor margin. Whether embolization is appropriate for a given tumor is determined by the multidisciplinary surgical and interventional team based on tumor type, vascularity, and location.
Which Tumor Types Are Commonly Discussed in This Context?
Pre-surgical embolization is discussed across several tumor categories in the interventional literature, including certain hypervascular bone and soft tissue tumors, meningiomas, and other lesions where imaging demonstrates a prominent, embolization-accessible vascular supply. Not every tumor is suited to this approach—tumor vascularity, feeding vessel accessibility, and proximity to critical structures all factor into the multidisciplinary decision.
What Embolic Materials Are Used?
Material selection depends on the target vessel architecture and clinical goal, and is determined by the treating interventional physician. Categories discussed in this context include:
- Particles or microspheres: often used to achieve distal, small-vessel occlusion within the tumor's vascular bed.
- Liquid embolic agents: such as EVOH copolymer-based systems, which may be selected when a physician wants controlled penetration into a complex or diffuse tumor vasculature.
- Coils: sometimes used adjunctively to occlude larger, more discrete feeding vessels.
Access to the tumor's vascular supply is typically achieved with microcatheters designed for selective catheterization, such as INVAMED's MicroCATH family, which supports delivery of liquid embolic agents, coils, and other embolic materials.
What Are the Procedural and Timing Considerations?
Timing between embolization and surgical resection is an important planning consideration—embolization is often performed close to the surgical date to limit the window in which collateral vessels might reconstitute blood flow to the tumor. The interventional and surgical teams typically coordinate closely on scheduling, imaging review, and anticipated intraoperative findings.
As with all embolization procedures, risks include non-target embolization, post-embolization syndrome, and the general risks associated with catheter-based vascular access. These risks are weighed against anticipated surgical benefit by the treating physician team on a case-by-case basis.
Frequently Asked Questions
How soon before surgery is pre-surgical embolization typically performed?
Timing varies by case and institutional protocol, often ranging from within 24–72 hours of surgery to reduce the likelihood of collateral vessel reconstitution, though this is determined by the treating physician team based on tumor characteristics and surgical scheduling.
Does pre-surgical embolization reduce tumor size?
Pre-surgical embolization is primarily intended to reduce blood flow to facilitate a safer surgical resection, rather than to shrink the tumor itself. Any change in tumor size is not the primary procedural goal and is not guaranteed.
Which specialties are typically involved in this decision?
Decisions about pre-surgical embolization typically involve a multidisciplinary discussion among interventional radiologists or neurointerventionalists and the surgical team responsible for the planned resection, based on imaging and tumor characteristics.
Related INVAMED Resources
- LIBRO Non-Adhesive Embolization Agent
- MicroCATH Neurovascular Catheter Family
- Embolization Products at INVAMED
Medical Disclaimer: This article is provided for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It is not a substitute for consultation with a qualified healthcare professional. Product indications, availability, and regulatory status vary by country. Always refer to the official Instructions for Use (IFU) and consult a licensed physician for guidance specific to your situation. INVAMED devices are intended for use by trained healthcare professionals.